ASBMT Pharmacy Special Interest Group (SIG) Update 2014 2015 Jamie F - PDF document

1/21/2015 ASBMT Pharmacy Special Interest Group (SIG) Update 2014 ‐ 2015 Jamie F Shapiro, Pharm.D, BCOP Clinical Pharmacy Coordinator, Stem Cell Transplant Chair, ASBMT Pharmacy SIG February 13, 2015 Disclosures • I have no relevant disclosures Objectives • Review the current initiatives of the Working Committees • Outline achievements accomplished by Pharmacy SIG Steering Committee and Working Committees • Discuss future directions for the Pharmacy SIG Working Committees 1

1/21/2015 ASBMT Pharmacy SIG Audience Response Question # 1 Which of the following statements is true? a ) In order to become a working committee member of the ASBMT Pharmacy SIG, you have to be a SIG member b) There is a small fee if you are an ASBMT member to become a member of the Pharmacy SIG c) Members of the Pharmacy SIG have many responsibilities, calls, and tasks throughout the year d) The applications for working committees are accepted twice a year SIG Structure and Function Steering Committee Communications Program Advocacy Education Research Membership (Website ) Planning and Policy Membership • February 2014 – 99 members • September 30, 2014 – 131 members (32% increase) • Continued Recruitment Initiatives  Booth exchange with HOPA at annual meeting  Maintenance of membership database  Letters to PGY2 directors highlighting benefits of membership including: — Reduced membership fee for residents in training — Networking — Opportunities for leadership 2

1/21/2015 Membership • New Initiatives and Roles  Awards — Selection of recipients for Lifetime Achievement Award and New Practitioner Award  Shared advertising with International Society of Oncology Pharmacy Practitioners (ISOPP) website  Defined “Role of HCT Pharmacists” on ASBMT Pharmacy SIG website Membership: Future Initiatives • Letter to BMT directors about new FACT CE requirements for Pharm.D • Awards  Expansion of awards offered: research or literature award • Develop novel methods for recruitment  Increase membership by 25% • Initiate collaboration with Schools of Pharmacy  Developing survey to send out to schools to identify and assess needs for HCT lecture Communications: Accomplishments • 3 newsletters published • Maintains and updates content for ASBMT Pharmacy SIG website 3

1/21/2015 Communications: New Initiatives • Guidelines established for contributors and reviewers of newsletter for:  Developing educational content  Article selection and review • Literature email updates sent out monthly • Promotion of Clinical Case Forum Clinical Case Forum • Multidisciplinary case ‐ based forum for addressing clinical conundrums in practice • Collaborate with other Pharm.D, MD, APP, nursing regarding complex cases  Over 4000 users across globe • Pharmacy Group developed our own section within site Communications: Future Goals • Expansion of educational materials housed on website and in newsletter with Education Committee • Develop relationship with student organizations and residency programs highlighting HCT pharmacy as profession • Open lines of communication with other pharmacy organizations to improve collaborative practice 4

1/21/2015 Program Planning • Continued and Future initiatives  Execute quality educational program for HCT Pharmacists  Continue to utilize technology to enhance experience of audience  Collaborate with multi ‐ disciplinary SIG to order to develop programming for larger audience  Offer additional professional networking at conference  Evaluate opportunities for Pharmacy SIG sponsored symposium at BMT Tandem Meeting Advocacy and Policy • Updates SIG members about current events affecting HCT Pharmacy population  Board of Pharmacy Specialties (BPS) solicited feedback regarding BPS Pharmacy Specialty Structure and Framework paper — BCOP would obtain subspecialty designation for HCT  Addressed BPS paper by developing survey to assess HCT pharmacists and their views on subspecialty creation and added qualifications (AQ) to represent HCT community — 81 responded (45 for subspecialty, 36 against) Advocacy and Policy: Response to BPS • Pharmacy SIG commented:  Subspecialty will recognize that practicing in HCT does require additional knowledge and practice beyond BCOP  Subspecialty designation would not likely create new job opportunities, justify more full ‐ time employees, increase compensation  Respondents would rather earn more CE vs. taking exam  Would consider AQ if subspecialty not adopted 5

1/21/2015 Advocacy and Policy: Response to BPS • Questions posed to BPS:  How will CE opportunities be provided and regulated for the subspecialty?  How will earning subspecialty designation lend to increased opportunities for pharmacists? • Very well received by BPS Advocacy and Policy: Accomplishments and Future Projects • Poster 5644: “Results of the ASBMT Pharmacy SIG Practice Survey – Understanding Today to Meet the Needs of Tomorrow” • Recognition letters for Working Committee Members • Advocacy 101 Guide • Develop mentoring program Education Current Initiatives • Fundamentals of HCT 2014  74 attendees (34% increase) • Next Fundamentals will be in Austin, TX following HOPA meeting, March 28 ‐ 29, 2015  8 hours CE  Flash drive with ALL course materials for attendees (plus available for purchase for those not able to attend meeting)  Open to all disciplines, ACPE, nursing CE • $245 registration 6

1/21/2015 Education: Fundamentals Course Topic Speaker Introduction to Transplant Susannah Koontz Mobilization Aimee Hammerstrom Preparative Regimens Cathryn Jennisen Complications of Transplant Alex Ganetsky Fungal and Viral Infections Kristen Held Bacterial Infections Aimee Hammerstrom GVHD ‐ Acute Susie Liewer GVHD ‐ Chronic Ryan Bookout BMT Pharmacy Practice Models Michael Westmoreland Melisa Stricherz Kamakshi Rao Education: Upcoming Events • Online case series housed on Pharmacy SIG webpage associated with lectures given at BMT Pharmacists Conference at the BMT Tandem Meetings • Intend to provide ACPE in future • Future initiatives  Work with communications committee to utilize ASBMT Pharmacy SIG Website to post educational resources and standards of care guidelines  Provide programming/ACPE for advanced practitioners  Work with NMDP System Capacity Initiative Group to support need for educational opportunities  Develop ASBMT Guidelines in collaboration with physicians Research • Reviewed abstracts submitted to pharmacy category for the BMT Tandem Meeting and selected 4 top abstracted to be presented  21 abstracts submitted • Busulfan pharmacokinetic protocol being submitted through multiple IRBs • Development of policy for conducting research within ASBMT Pharmacy SIG with intention to publish 7

1/21/2015 Research Policy • Purpose: to recognize individuals collaborating with projects, i.e. responses to surveys and list serv questions • Requires proposal submitted to chair of Research Working committee • Policy does not apply to surveys/questions asked for purposes of application for clinical practice only, as long as material is not shared as presentation/publication Research: Future Initiatives • Identify ways to encourage and support pharmacist led research in HCT • Evaluate funding opportunities for research with Pharmacy SIG • Collaborate on research protocols • Consider a research “boot camp” at Tandem meeting Steering Committee • Selection of working committee members • Maintains and updates charters and policy and procedures • Oversees all activities of Working Committees • Provides guidance on new initiatives and policies • Submits proposals to ASBMT Executive Committee (EC) as needed • Provides communication between ASBMT EC and working committees • Responds to HCT related pharmacy issues 8

1/21/2015 Steering Committee: Responds to CMS Part D Immunosuppressants • CMS proposed to remove immunosuppressants from list of drugs in protected class as part of Part D formulary • NMDP asked for Steering committee assistance in drafting letter to CMS • Letter discussed importance of availability of immunosuppressants and that they are not interchangable ASBMT Pharmacy SIG Audience Response Question # 2 The revised FACT/JACIE Standards 6 th edition states that pharmacists are now required to obtain how many hours of continuing education. a.) 20 b.) 10 c.) 0 d.) 5 9

1/21/2015 Foundation for the Accreditation of Cellular Therapy (FACT) 6 th edition • NMDP System Capacity Initiative (SCI)  Strengthen role of Pharm.D as part of multidisciplinary team and include essential roles and responsibilities — Training includes: overview of cellular process, therapeutic drug monitoring, adjustments of drugs for organ dysfunction — Pharmacists should be involved in development of guidelines/standard operating procedures (SOP) • Steering Committee asked to provide feedback on proposed Standards FACT 6 th edition • New requirements for APP, Pharm.D, Nursing  Include 10 hours of educational activities related to cellular therapy annually — Can include attending conferences, institutional grand rounds, reviewing journal articles…. — Key will be to maintaining documentation  Title of activity, type of activity (webinar, meeting, grand round), topic of activity, date of activity, approximate number of hours • Responsibility of clinical program to inform staff about FACT standards changes • New guidelines to be released March 2015 FACT 6 th edition: Looking Ahead • Discussion to participate in webinar defining role of Pharm.D in HCT with collaboration from FACT and NMDP 10